Sandu Pharmaceuticals

quarterly
yearly
ParticularsDec '21Mar '22Jun '22Sep '22Dec '22
Revenue19.1511.4216.2316.7617.09
Expenses18.5210.9816.0316.0316.40
EBITDA0.630.440.200.730.69
EBIT0.500.310.070.600.56
Profit Before Tax0.630.450.260.880.70
Net Profit0.450.270.170.600.48
Financial Ratios
Operating Profit Margin3.29%3.85%1.23%4.36%4.04%
Net Profit Margin2.35%2.36%1.05%3.58%2.81%
Earning Per Share (Diluted)0.570.260.180.680.51
Dividends Per ShareNA0.75NANANA
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 3.8.0
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI